Glaxosmithkline Consumer Healthcare Profile
Key Indicators
- Authorised Capital ₹ 60.00 Cr
as on 02-05-2024
- Paid Up Capital ₹ 42.06 Cr
as on 02-05-2024
- Company Age 66 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 279.50 Cr
as on 02-05-2024
- Revenue 12.52%
(FY 2019)
- Profit 40.38%
(FY 2019)
- Ebitda 29.16%
(FY 2019)
- Net Worth 17.49%
(FY 2019)
- Total Assets 12.11%
(FY 2019)
About Glaxosmithkline Consumer Healthcare
- CIN/LLPIN
L24231PB1958PLC002257
- Company No.
002257
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Oct 1958
- Date of AGM
02 Aug 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Listed
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Glaxosmithkline Consumer Healthcare?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navneet Saluja  | Managing Director | 01-Jan-2018 | Current |
| Shanu Saksena | Company Secretary | 05-Aug-2016 | Current |
| Nitin Mathur | CFO | 01-Nov-2019 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subramanian Madhavan | Director | 25-Sep-2018 | Current |
| Sangeeta Talwar | Director | 06-Aug-2014 | Current |
| Pradeep Bhide | Director | 10-May-2019 | Current |
| Patnam Dwarakanath | Nominee Director | 30-Apr-2004 | Current |
| Anup Dhingra | Whole-Time Director | 01-Sep-2016 | Current |
Financial Performance and Corporate Structure Insights of Glaxosmithkline Consumer Healthcare.
Glaxosmithkline Consumer Healthcare Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 12.52% increase. The company also saw a substantial improvement in profitability, with a 40.38% increase in profit. The company's net worth Soared by an impressive increase of 17.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glaxosmithkline Consumer Healthcare?
In 2019, Glaxosmithkline Consumer Healthcare had a promoter holding of 72.46% and a public holding of 27.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Deutsche Bank Creation Date: 22 Dec 2006 | ₹53.00 Cr | Satisfied |
Bank Of America Creation Date: 26 Jul 1995 | ₹200.00 Cr | Satisfied |
Bank Of America Nt And Sa Creation Date: 23 Mar 1993 | ₹26.50 Cr | Satisfied |
How Many Employees Work at Glaxosmithkline Consumer Healthcare?
Glaxosmithkline Consumer Healthcare has a workforce of 1297 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Consumer Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Consumer Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
